XHKG
3600
Market cap882mUSD
Oct 09, Last price
7.64HKD
1D
3.10%
1Q
10.56%
Jan 2017
168.07%
IPO
84.54%
Name
Modern Dental Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Modern Dental Group Limited, an investment holding entity, is a prominent provider specializing in the manufacturing and worldwide distribution of dental prosthetic devices. Its extensive operations reach various international markets, including Europe, Greater China, North America, and Australia. The company's offerings are structured across three primary segments. The Fixed Prosthetic Devices division provides restorative dental solutions such as crowns, bridges, and implants. Concurrently, the Removable Prosthetic Devices segment is dedicated to producing both full and partial dentures, which can include metal frameworks or be entirely metal-free. Furthermore, its "Others" segment encompasses a diverse range of products like orthodontic appliances, sports guards, anti-snoring devices, raw materials, and various dental equipment. This segment also extends to offering professional services, including educational events and seminars. Modern Dental Group serves a broad clientele comprising dentists, dental clinics, hospitals, distributors, and other professional customers. Its comprehensive product line is marketed under numerous recognized brands, such as Permadental & Semperdent, Schmidt, Apex Digital Dental, Elysee, Labocast, Modern Dental Laboratory, Yangzhijing, Southern Cross Dental, Andent, Modern Dental USA, Sundance Dental, Quantum Dental, TrioClear, and Digitek Dental. The company was established in 1986 and is headquartered in Kowloon, Hong Kong.
Key people
Kwun Fung Chan
Executive Chairman of the Board · since 2012
Chief Financial Officer, Company Secretary · since 2016
Christopher Aughton
Chief Executive Officer - SCDL Group · since 2015
August Wilhelm Torsten Schwafert
Chief Executive Officer - Europe Holding Netherlands · since 2014
Gregory Scialom
President - Labocast · since 2011
Chi Ho Alwin Ngai
Chief Operating Officer, Executive Director · since 2015
Yik long Chan
General Manager, Executive Director - MDLCl · since 2014
Yik Yu Chan
Chief Marketing Officer, Executive Director · since 2014
Shing Kin Ngai
Chief Executive Officer, Executive Director · since 2012
Chi Yuen Chan
Executive Director, Chief Operating officer of YZJSZ · since 2014
Kwun Pan Chan
Executive Vice Chairman of the Board · since 2012
Non-Executive Independent Director · since 2015
Wai Man Cheung
Non-Executive Independent Director · since 2015
Non-Executive Independent Director · since 2015
Ho Ching Wong
Non-Executive Independent Director · since 2015
Legal address
c/o CONYERS TRUST COMPANY (CAYMAN) LIMITED, Cricket Square, Hutchins Drive P.O. Box 2681
Grand Cayman KY1-1111
KY
Grand Cayman KY1-1111
KY
Headquarters
Units 1708-16 17/F, CEO Tower, 77 Wing Hong Street, Cheung Sha Wan, Kowloon
Hong Kong
HK
Hong Kong
HK
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||